Cargando…

Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network

Additional sex combs-like 1 (ASXL1) interacts with BRCA1-associated protein 1 (BAP1) deubiquitinase to oppose the polycomb repressive complex 1 (PRC1)-mediated histone H2A ubiquitylation. Germline BAP1 mutations are found in a spectrum of human malignancies, while ASXL1 mutations recurrently occur i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Yu-Kun, Zeng, Yi-Rong, Zhang, Meng-Li, Liu, Peng, Liu, Fang, Zhang, Hao, He, Chen-Xi, Sun, Yi-Ping, Zhang, Jin-Ye, Zhang, Cheng, Song, Lei, Ding, Chen, Tang, Yu-Jie, Yang, Zhen, Yang, Chen, Wang, Pu, Guan, Kun-Liang, Xiong, Yue, Ye, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225741/ https://www.ncbi.nlm.nih.gov/pubmed/32683582 http://dx.doi.org/10.1007/s13238-020-00754-2

Ejemplares similares

Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex
por: Balasubramani, Anand, et al.
Publicado: (2015)

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
por: Asada, Shuhei, et al.
Publicado: (2018)

Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1
por: Daou, Salima, et al.
Publicado: (2018)

BAP1/ASXL1 recruitment and activation for H2A deubiquitination
por: Sahtoe, Danny D., et al.
Publicado: (2016)

ASXL1 plays an important role in erythropoiesis
por: Shi, Hui, et al.
Publicado: (2016)

Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer
por: Tsuboyama, Natsumi, et al.
Publicado: (2022)

BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion
por: Perez-Garcia, Vicente, et al.
Publicado: (2021)

ASXL1/2 mutations and myeloid malignancies
por: Medina, Edward A., et al.
Publicado: (2022)

ASXL1 mutations in Chinese patients with essential thrombocythemia
por: Nie, Yan-Bo, et al.
Publicado: (2018)

Structural basis of histone H2A lysine 119 deubiquitination by Polycomb Repressive Deubiquitinase BAP1/ASXL1
por: Thomas, Jonathan F., et al.
Publicado: (2023)

Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1
por: Thomas, Jonathan F., et al.
Publicado: (2023)

Examining the neurodevelopmental and motor phenotypes of Bohring-Opitz syndrome (ASXL1) and Bainbridge-Ropers syndrome (ASXL3)
por: Ayoub, Maya C., et al.
Publicado: (2023)

ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer
por: Szczepanski, Aileen Patricia, et al.
Publicado: (2020)

Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish
por: Fang, Xiao, et al.
Publicado: (2021)

Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish
por: Gjini, Evisa, et al.
Publicado: (2019)

ASXL1 interacts with the cohesin complex to maintain chromatid separation and gene expression for normal hematopoiesis
por: Li, Zhaomin, et al.
Publicado: (2017)

Loss of Asxl2 leads to myeloid malignancies in mice
por: Li, Jianping, et al.
Publicado: (2017)

Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fates
por: Zhang, Peng, et al.
Publicado: (2018)

Role of ASXL1 mutation in impaired hematopoiesis and cellular senescence
por: Uni, Masahiro, et al.
Publicado: (2018)

Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
por: Fan, Yi, et al.
Publicado: (2021)

Circ-ITGA7 sponges miR-3187-3p to upregulate ASXL1, suppressing colorectal cancer proliferation
por: Yang, Guangpu, et al.
Publicado: (2019)

SETBP1 Mutations Drive Leukemic Transformation in ASXL1-Mutated MDS
por: Inoue, Daichi, et al.
Publicado: (2014)

Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
por: Abdel-Wahab, Omar, et al.
Publicado: (2013)

PR-DUB maintains the expression of critical genes through FOXK1/2- and ASXL1/2/3-dependent recruitment to chromatin and H2AK119ub1 deubiquitination
por: Kolovos, Petros, et al.
Publicado: (2020)

ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen
por: Wang, Liang, et al.
Publicado: (2021)

“ASXL1”-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
por: Gleitz, Hélène F.E., et al.
Publicado: (2022)

Deregulation of tumor suppressive ASXL1−PTEN/AKT axis in myeloid malignancies
por: Cao, Lei, et al.
Publicado: (2020)

RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
por: Bera, Rabindranath, et al.
Publicado: (2019)

CHIP‐associated mutant ASXL1 in blood cells promotes solid tumor progression
por: Liu, Xiaoxiao, et al.
Publicado: (2022)

Acute myeloid leukemia in a father and son with a germline mutation of ASXL1
por: Seiter, Karen, et al.
Publicado: (2018)

Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation
por: Nagase, Reina, et al.
Publicado: (2018)

Pathological ASXL1 Mutations and Protein Variants Impair Neural Crest Development
por: Matheus, Friederike, et al.
Publicado: (2019)

Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia
por: Bidikian, Aram, et al.
Publicado: (2022)

Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen
por: Wang, Liang, et al.
Publicado: (2023)

ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
por: Rahmani, Nora E., et al.
Publicado: (2021)

Functional and cancer genomics of ASXL family members
por: Katoh, M
Publicado: (2013)

Hcfc1a regulates neural precursor proliferation and asxl1 expression in the developing brain
por: Castro, Victoria L., et al.
Publicado: (2020)

A de novo Variant of ASXL1 Is Associated With an Atypical Phenotype of Bohring-Opitz Syndrome: Case Report and Literature Review
por: Zhao, Weiqing, et al.
Publicado: (2021)

Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia
por: Cui, Yajuan, et al.
Publicado: (2015)

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
por: Gelsi-Boyer, Véronique, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_08kag2im94942ul63fcobv6afd